|
MAGEF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.527780E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.116900E-03 |
| Normal-vs-Stage2 |
5.374400E-02 |
| Normal-vs-Stage3 |
1.518200E-01 |
| Normal-vs-Stage4 |
5.704800E-03 |
| Stage1-vs-Stage2 |
9.804800E-01 |
| Stage1-vs-Stage3 |
5.627400E-01 |
| Stage1-vs-Stage4 |
2.028800E-01 |
| Stage2-vs-Stage3 |
6.884000E-01 |
| Stage2-vs-Stage4 |
2.543600E-01 |
| Stage3-vs-Stage4 |
1.924390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.481700E-02 |
| Normal-vs-AfricanAmerican |
2.690200E-02 |
| Normal-vs-Asian |
2.517800E-02 |
| Caucasian-vs-AfricanAmerican |
8.764800E-01 |
| Caucasian-vs-Asian |
2.329800E-01 |
| AfricanAmerican-vs-Asian |
2.290600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.154300E-04 |
| Normal-vs-Female |
7.042800E-01 |
| Male-vs-Female |
1.295650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.579600E-02 |
| Normal-vs-Extreme_Weight |
1.403970E-02 |
| Normal-vs-Obese |
5.016500E-02 |
| Normal-vs-Extreme_Obese |
6.623000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.700200E-01 |
| Normal_Weight-vs-Obese |
6.326400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.100000E-01 |
| Extreme_Weight-vs-Obese |
4.729800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.697200E-01 |
| Obese-vs-Extreme_Obese |
4.292200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.441700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.428040E-01 |
| Normal-vs-Age(61-80Yrs) |
3.184100E-03 |
| Normal-vs-Age(81-100Yrs) |
7.182000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.987400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.018400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.262000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.594400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.090650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.383800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.518200E-02 |
| Normal-VS-Type2 PRCC |
1.218950E-04 |
| Normal-VS-KIRP CIMP |
8.958000E-02 |
| Normal-VS-Unclassified PRCC |
1.355960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.029700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.090000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.820400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.165600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.059900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.661200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.359600E-03 |
| Normal-vs-N1 |
1.468830E-01 |
| Normal-vs-N2 |
2.069800E-01 |
| N0-vs-N1 |
3.571200E-01 |
| N0-vs-N2 |
9.691200E-01 |
| N1-vs-N2 |
6.722800E-01 |
|
|
